Danone Stock Price, News & Analysis

Danone (OTC:DANOY) has successfully completed the acquisition of a majority stake in Kate Farms, the leading doctor-recommended plant-based nutrition brand in the United States. The strategic acquisition enhances Danone's specialized nutrition portfolio in North America by combining Kate Farms with its existing brands Nutricia, Real Food Blends, and Functional Formularies.

Brett Matthews, former CEO and Chairman of Kate Farms, will serve as Chairman and CEO of the combined business effective immediately. The integration aims to expand access to specialized nutrition across various channels including hospitals, homes, online platforms, and retail shelves.

Kate Farms, founded to address a critical need for allergen-free tube feeding formula, has grown to become a major player in the specialized nutrition space with products available in over 1,400 U.S. hospitals. The company's products are eligible for insurance coverage through Medicare, Medicaid, private insurance, and WIC in 33+ states. This acquisition aligns with Danone's Renew strategy and builds upon its existing €27.4 billion in sales reported for 2024.

[ "Acquisition strengthens Danone's position in the U.S. specialized nutrition market", "Integration combines #1 doctor-recommended plant-based brand with Danone's existing nutrition portfolio", "Expanded distribution network across 1,400+ U.S. hospitals", "Strong insurance coverage including Medicare, Medicaid, and WIC in 33+ states", "Retention of successful Kate Farms management team ensures continuity" ]

Danone (OTC:DANOY) has announced the acquisition of The Akkermansia Company (TAC), a Belgian biotic specialist with nearly 20 years of expertise. TAC is known for its groundbreaking 2004 discovery of Akkermansia muciniphila MucT™, a biotic strain clinically proven to strengthen gut barriers, reduce inflammation, and combat metabolic disorders including obesity, diabetes, and cardiovascular disease.

This strategic acquisition aligns with Danone's Renew strategy, emphasizing scientific innovation and responding to growing consumer demand for health-focused products. The company, which generated €27.4 billion in sales in 2024, operates across three health-focused categories: Essential Dairy & Plant-Based products, Waters, and Specialized Nutrition, with products available in over 120 markets globally.

Danone (DANOY) has disclosed its latest share and voting rights data as of May 31, 2025. The company reported a total of 681,068,400 shares outstanding. The total number of theoretical (gross) voting rights stands at 718,099,987, while the exercisable (net) voting rights amount to 680,003,319. This disclosure is in compliance with French regulatory requirements, specifically Article L. 233-8 II of the French Commercial Code and Article 223-16 of the AMF General Regulation. The difference between theoretical and exercisable voting rights indicates shares with suspended voting rights.

Danone (DANOY) announced that Shane Grant, Group Deputy CEO, CEO Americas and EVP Dairy, Plant-Based and Global Sales, will be leaving the company effective June 13th, 2025 to pursue new opportunities. Véronique Penchienati-Bosetta, current Group Deputy CEO, will temporarily assume Grant's responsibilities in addition to her existing duties. Grant, who joined Danone in 2020, has been credited with advancing the company's business across North and Latin America, commercial teams, and categories.

Danone (DANOY) has disclosed its latest share and voting rights information as of April 30, 2025. The company reported a total of 679,553,991 shares outstanding. The total number of theoretical (gross) voting rights stands at 699,851,306, while the total number of exercisable (net) voting rights is 661,754,638. This disclosure is in compliance with French regulatory requirements, specifically Article L. 233-8 II of the French Commercial Code and Article 223-16 of the AMF General Regulation. The difference between theoretical and exercisable voting rights represents shares with suspended voting rights.

Danone (DANOY) has announced a definitive agreement to acquire a majority stake in Kate Farms, a U.S.-based company specializing in plant-based, organic nutrition products for medical and everyday needs. The strategic partnership aims to enhance Danone's specialized nutrition offerings and expand Kate Farms' reach both in the U.S. and internationally. Brett Matthews, Kate Farms' current CEO, will become Chairman and CEO of Danone's North American Medical Nutrition business post-acquisition, while Kate Farms' senior management will retain a minority stake. Kate Farms, founded to help a young girl named Kate who couldn't tolerate traditional tube feeding formulas, now provides nutritional products available in over 1,400 U.S. hospitals and is eligible for insurance coverage through Medicare, Medicaid, private insurance, and WIC in 33+ states. The transaction is subject to customary closing conditions and regulatory approval.

Danone held its 2025 Shareholders' Meeting with 72.66% of total outstanding share capital represented. Shareholders approved all resolutions, including financial statements for 2024 and a cash dividend of €2.15 per share, representing a 2.4% increase from previous year. The dividend ex-date is set for May 5, 2025, with payment on May 7, 2025.

The meeting approved renewals for Antoine de Saint-Affrique (CEO) and independent directors Patrice Louvet, Géraldine Picaud, and Susan Roberts. Additionally, Danone continues its global Employee Share Subscription Plan, allowing international employees from 48 countries to subscribe to new shares at a 30% discount from the reference price, covering approximately 85% of worldwide employees.

Danone (DANOY) reported strong Q1 2025 performance with sales reaching €6,844 million, representing a +4.3% like-for-like growth. The growth was driven by both volume/mix (+1.9%) and price (+2.4%) increases across all categories.

Geographic performance highlights include: China, North Asia & Oceania showing exceptional growth of +9.9% LFL, North America delivering solid +3.7% growth led by High Protein products, and Europe achieving +2.0% growth with positive volume/mix for the sixth consecutive quarter.

By category, Specialized Nutrition grew +5.3%, Waters +4.1%, and EDP (Essential Dairy & Plant-based) +3.7%. The company completed a share buyback of 2.7 million shares for €192 million and issued an €800 million bond with an 8-year maturity. Danone confirmed its 2025 guidance with LFL sales growth expected between +3% and +5%, with recurring operating income growing faster than sales.

Danone (DANOY) has released its latest voting rights and shares report as of March 31, 2025. The company's total share capital consists of 679,553,991 shares, with 698,754,239 theoretical (gross) voting rights and 660,657,571 exercisable (net) voting rights.

The theoretical voting rights serve as the basis for calculating shareholding threshold crossings, including shares with suspended voting rights, in accordance with AMF General Regulation Article 223-11. The exercisable voting rights figure excludes shares with suspended voting rights and is published to ensure public transparency, following AMF's recommendation from July 17, 2007.